Browsing the "Biotech" Category



Pelago collaborates with Sygnature

Published on January 13th, 2017 | by Malin Anderson

UK’s Sygnature Discovery will collaborate with Swedish biotech company Pelago Bioscience to provide target engagement assays with Pelago’s patented Cellular Thermal Shift Assay (CETSA) method. Pelago’s CETSA method enables measurements to be made within cellular systems. more »Read More


Oresund Bridge

BIO-Europe to be held in Medicon Valley

Published on December 2nd, 2016 | by Malin Anderson

Europe’s largest biotech conference BIO-Europe will be held in Copenhagen and Malmö in 2018. A contributing factor to the decision was the strong Swedish-Danish cooperation between the private and public sectors. According to Novo Nordisk, one more »Read More



Denmark’s biotech sector best in Europe  

Published on September 7th, 2016 | by Malin Anderson

For the second year running, Denmark’s biotech sector is awarded a global top three ranking by Scientific American Worldview and is praised for its generous public sector investment and speedy drug trial application process. Denmark takes more »Read More


exini ceo

Progenics announces offer to acquire EXINI

Published on October 19th, 2015 | by Malin Anderson

Progenics Pharmaceuticals has offered to acquire Swedish company EXINI Diagnostics through a public offer to the shareholders of EXINI. EXINI is headquartered in Lund, Sweden, and is listed on Nasdaq First North, Stockholm. The company develops more »Read More



NOK 250 million to biotech

Published on October 12th, 2015 | by Malin Anderson

The Research Council of Norway has awarded NOK 250 million in funding under the new biotechnology initiative on digital life for the establishment of a national centre. Six large-scale Researcher Projects will be carried out under more »Read More



Xbrane acquires Primm Pharma

Published on October 5th, 2015 | by Malin Anderson

Xbrane has acquired the Italian based Primm Pharma and completed a distribution deal with the Iranian company Pooyesh Darou. Xbrane is a commercial phase Swedish biopharmaceutical company specialized in High Demand Complex Generics. Primm Pharma specializes more »Read More



Biotech Firm Wins Pitch Contest

Published on May 13th, 2015 | by Ellen R. Delisio

MyOroface, a biotech Umeå and Uminova Innovation supported company, won 100,000 SEK at the ALMI Invests pitch competition. Twenty business ideas were selected to give their company pitch in front of an experienced investors’ panel, which more »Read More



Norway Joins Biotech Assoc.

Published on November 6th, 2014 | by Ellen R. Delisio

The Norwegian Bioindustry Association is one of 20 founding members of the International Council of Biotechnology Associations (ICBA). The goal of the ICBA is to advocate for public policies that support the growth of the biotechnology more »Read More



Denmark’s biotech pipeline on top

Published on October 7th, 2014 | by Anneli Hidalgo

Danish biotech and drug companies are among the best in Europe when it comes to the number of candidate drugs under development, according to a new study. Nordic Life Sciences sector study 2014, by Ernst & more »Read More



Danish biotech company among top SMEs

Published on September 10th, 2014 | by Anneli Hidalgo

The European Association for Bioindustries has announced the top five biotech SMEs in Europe and Danish Biosyntia is among the five contenders. Biosyntia and the other four companies will compete to win the award as the ‘Most Innovative more »Read More


BerGenBio granted platform patent

Published on September 8th, 2014 | by Anneli Hidalgo

The Norwegian oncology biopharmaceutical company has announced that the United States Patent and Trademark Office (USPTO) has issued United States Patent 8,735,064 covering a method for creating and identifying functional interference RNA (RNAi) molecules. RNAis are recombinant nucleic acid more »Read More



BioGaia expands with new production facility

Published on June 30th, 2014 | by Anneli Hidalgo

BioGaia’s subsidiary TwoPac is setting up another production unit in Eslöv, in the south of Sweden. TwoPac AB was founded in 2002 to develop and manufacture packaging solutions for probiotics and is since June 2013 entirely more »Read More



Novozymes to open new R&D center in the US

Published on April 3rd, 2014 | by Anneli Hidalgo

Novozymes has announced the establishment of a new research and development center in the US dedicated to its bioagriculture business. The center will be located near the Research Triangle Park in Cary, North Carolina where the more »Read More



No preliminary investigation on Active Biotech

Published on March 31st, 2014 | by Anneli Hidalgo

In the end of February Active Biotech was reported to the Swedish Economic Crime Authority, which has now decided not to precede with a preliminary investigation. The complaint to the Swedish Economic Crime Authority came from the more »Read More



Active Biotech reported for economic crime

Published on February 27th, 2014 | by Anneli Hidalgo

The Lund-based pharmaceutical company has been reported to the Swedish Economic Crime Authority. Active Biotech is accused to have to misinformed their investors. Allegedly, the firm was aware of the that the MS drug Nerventra should more »Read More

Back to Top ↑
  • Laddar

  • Newsletter – Sign up for free